1,
SUMMARYThe changes seen in EEG activity with administration of long-acting benzodiazepines are a significant decrease In delta, 0.5-3 Hz, and a significant increase in sleep spindles, bursts of 11-15 Hz activity. These changes often persist for several days after the medication is discontinued.The introduction of a new benzodiazepine hypnotic, triazolam, in which the half-life of both the parent compound and its metabolite is less than 10 hours, raises questions as to whether its use will produce similar EEG changes during sleep and whether there will be a build-up effect over nights. Of particular interest is whether electrophysiological and performance changes will persist at the same level during a 7.5-hour sleep period and whether there will be a quick return to baseline EEG activity during withdrawal. As part of a larger study on the effects of benzodiazepines on EEG, sleep, arousal levels, and performance, delta and spindle activity were measured during baseline, treatment, and withdrawal. The auditory cortical evoked potential was also obtained during the last baseline and during the fifth drug night.Twenty male chronic poor sleepers, mean age 21.02 ± 2.37 years, with EEG measured sleep latencies of greater than 30 minutes, participated in the double-blind study. All received a placebo for 3 nights, 10 continued to receive the placebo and 10 were given 0.5 mg triazolam for 6 nights, and all received placebo on 2 withdrawal nights. Subjects received click stimulation on the last night of the baseline and the fifth night of hypnotic administration (study nights 4 and 9).Subjects receiving triazolam showed a significant increase in sleep spindles and a significant decrease in delta count during drug administration. Both values returned to baseline on the first withdrawal night. The auditory evoked potential (AEP) peak-to-trough amplitude was also significantly reduced during sleep by triazolam, but, as the time since drug ingestion increased, the amplitude of the AEP also increased. There was no difference in AEP amplitude between the two groups 5 hours post-drug ingestion.In morning performance batteries, there were no cognitive or visual motor performance decrements. While the long-acting metabolites of some benzodiazepines, further influenced by dose levels, may be the neuropharmacological basis for daytime performance decrements, these data indicate that the EEG changes occur in the absence of long-acting metabolites. As with flurazepam, there was no relationship between the EEG changes, sleep efficiency, and morning performance.2